217 related articles for article (PubMed ID: 35876294)
1. Predictors of adherence to oral anticancer medications: An analysis of 2010-2018 US nationwide claims.
Vyas A; Descoteaux A; Kogut S; Parikh MA; Campbell PJ; Green A; Westrich K
J Manag Care Spec Pharm; 2022 Aug; 28(8):831-844. PubMed ID: 35876294
[No Abstract] [Full Text] [Related]
2. Assessing the association between medication adherence, as defined in quality measures, and disease-state control, health care utilization, and costs in a retrospective database analysis of Medicare supplemental beneficiaries using statin medications.
Axon DR; Vaffis S; Chinthammit C; Lott BE; Taylor AM; Pickering M; Black H; Warholak T; Campbell PJ
J Manag Care Spec Pharm; 2020 Dec; 26(12):1529-1537. PubMed ID: 33251989
[No Abstract] [Full Text] [Related]
3. Impact of Out-of-Pocket Pharmacy Costs on Branded Medication Adherence Among Patients with Type 2 Diabetes.
Bibeau WS; Fu H; Taylor AD; Kwan AY
J Manag Care Spec Pharm; 2016 Nov; 22(11):1338-1347. PubMed ID: 27783549
[TBL] [Abstract][Full Text] [Related]
4. Evaluating the relationship between quality measure adherence definitions and economic outcomes in commercial health plans: a retrospective diabetes cohort study.
Chinthammit C; Axon DR; Mollon L; Taylor AM; Pickering M; Black H; Warholak T; Campbell PJ
J Manag Care Spec Pharm; 2021 Jan; 27(1):64-72. PubMed ID: 33377445
[No Abstract] [Full Text] [Related]
5. Factors associated with medication nonadherence among Medicare low-income subsidy beneficiaries with diabetes, hypertension, and/or heart failure.
Steve Tsang CC; Browning J; Todor L; Dougherty S; Hohmeier KC; Sam Li M; Borja-Hart N; Hines LE; Wang J
J Manag Care Spec Pharm; 2021 Aug; 27(8):971-981. PubMed ID: 34337985
[No Abstract] [Full Text] [Related]
6. The effects of oral anticancer parity laws on out-of-pocket spending and adherence among commercially insured patients with chronic myeloid leukemia.
Spargo A; Yost C; Squires P; Raju A; Schroader B; Brown JD
J Manag Care Spec Pharm; 2021 May; 27(5):554-564. PubMed ID: 33908275
[No Abstract] [Full Text] [Related]
7. Association of Medication Adherence with Hospital Utilization and Costs Among Elderly with Diabetes Enrolled in a State Pharmaceutical Assistance Program.
Pednekar P; Heller DA; Peterson AM
J Manag Care Spec Pharm; 2020 Sep; 26(9):1099-1108. PubMed ID: 32857648
[TBL] [Abstract][Full Text] [Related]
8. Association of out-of-pocket pharmacy costs with adherence to varenicline.
Suehs BT; Davis C; Galaznik A; Joshi AV; Zou KH; Patel NC
J Manag Care Spec Pharm; 2014 Jun; 20(6):592-600. PubMed ID: 24856597
[TBL] [Abstract][Full Text] [Related]
9. It is time for a new comprehensive medication review quality measure.
Castora-Binkley M; Hines L; Vaffis S; Dhatt H; Anderson E; Le D; Black H; Campbell PJ; Kolobova I; Nelson M; Axon DR; Warholak T
J Manag Care Spec Pharm; 2023 Jun; 29(6):680-684. PubMed ID: 37276042
[TBL] [Abstract][Full Text] [Related]
10. Alignment of diagnosis and pharmacy claims data coding of medication adherence among patients with diabetes or hypertension.
Gatwood J; Hohmeier KC; Shuvo S; Mikaiel D; Kovesdy CP
J Manag Care Spec Pharm; 2021 Apr; 27(4):497-506. PubMed ID: 33769854
[No Abstract] [Full Text] [Related]
11. Patterns of care and costs of switching oral antipsychotic medications in patients with schizophrenia initiating monotherapy treatment: A US claims analysis.
Fee R; Webb N; Dick L; White J; Essoi B; Walker V; Zacker C
J Manag Care Spec Pharm; 2024 Jun; 30(6):560-571. PubMed ID: 38591754
[TBL] [Abstract][Full Text] [Related]
12. Predictors of Nonadherence to Topical Intraocular Pressure Reduction Medications Among Medicare Members: A Claims-Based Retrospective Cohort Study.
Sheer R; Bunniran S; Uribe C; Fiscella RG; Patel VD; Chandwani HS
J Manag Care Spec Pharm; 2016 Jul; 22(7):808-817a. PubMed ID: 27348282
[TBL] [Abstract][Full Text] [Related]
13. Clinical and economic burdens of recurrence following nephrectomy for intermediate high- or high-risk renal cell carcinoma: A retrospective analysis of Surveillance, Epidemiology, and End Results-Medicare data.
Sundaram M; Song Y; Rogerio JW; Zhang S; Bhattacharya R; Adejoro O; Carley C; Zhu JJ; Signorovitch J; Haas NB
J Manag Care Spec Pharm; 2022 Oct; 28(10):1149-1160. PubMed ID: 36048895
[No Abstract] [Full Text] [Related]
14. Comparison of Anticancer Medication Use and Spending Under US Oncology Parity Laws With and Without Out-of-Pocket Spending Caps.
Dusetzina SB; Huskamp HA; Jazowski SA; Winn AN; Basch E; Keating NL
JAMA Health Forum; 2021 May; 2(5):e210673. PubMed ID: 35977314
[TBL] [Abstract][Full Text] [Related]
15. Assessment of racial and ethnic inequities in copay card utilization and enrollment in copay adjustment programs.
Ingham M; Sadik K; Zhao X; Song J; Fendrick AM
J Manag Care Spec Pharm; 2023 Sep; 29(9):1084-1092. PubMed ID: 37548953
[No Abstract] [Full Text] [Related]
16. Health care resource utilization and costs associated with nonadherence and nonpersistence to antidepressants in major depressive disorder.
Ta JT; Sullivan SD; Tung A; Oliveri D; Gillard P; Devine B
J Manag Care Spec Pharm; 2021 Feb; 27(2):223-239. PubMed ID: 33506730
[No Abstract] [Full Text] [Related]
17. Association of Patient Out-of-Pocket Costs With Prescription Abandonment and Delay in Fills of Novel Oral Anticancer Agents.
Doshi JA; Li P; Huo H; Pettit AR; Armstrong KA
J Clin Oncol; 2018 Feb; 36(5):476-482. PubMed ID: 29261440
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Out-of-Pocket Costs and Treatment Intensification With an SGLT2 Inhibitor or GLP-1 RA in Patients With Type 2 Diabetes and Cardiovascular Disease.
Luo J; Feldman R; Callaway Kim K; Rothenberger S; Korytkowski M; Hernandez I; Gellad WF
JAMA Netw Open; 2023 Jun; 6(6):e2317886. PubMed ID: 37307000
[TBL] [Abstract][Full Text] [Related]
19. Does a One-Size-Fits-All Cost-Sharing Approach Incentivize Appropriate Medication Use? A Roundtable on the Fairness and Ethics Associated with Variable Cost Sharing.
Graff JS; Shih C; Barker T; Dieguez G; Larson C; Sherman H; Dubois RW
J Manag Care Spec Pharm; 2017 Jun; 23(6):621-627. PubMed ID: 28530519
[TBL] [Abstract][Full Text] [Related]
20. The Effect of Opioid Use and Mental Illness on Chronic Disease Medication Adherence in Superutilizers.
Surbhi S; Graetz I; Wan JY; Gatwood J; Bailey JE
J Manag Care Spec Pharm; 2018 Mar; 24(3):198-207. PubMed ID: 29485952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
